Skip to Content

IDenta Corp IDTA

Morningstar Rating
$0.22 +0.02 (8.75%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

IDTA is trading at a 48% discount.
Price
$0.22
Fair Value
$2.24
Uncertainty
Extreme
1-Star Price
$5.87
5-Star Price
$7.37
Economic Moat
Kxh
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if IDTA is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.20
Day Range
$0.220.22
52-Week Range
$0.100.50
Bid/Ask
$0.20 / $0.25
Market Cap
$879,915.61
Volume/Avg
1,854 / 2,622

Key Statistics

Price/Earnings (Normalized)
21.35
Price/Sales
0.98
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

IDenta Corp is a detection and forensic science company. The firm, through its subsidiary, is engaged in the business of developing products to test for the presence of illegal drugs and explosives for law enforcement agencies, the military, government agencies, and other organizations. Its product portfolio includes Drug testing kits, Explosive testing kits, Precursors of Drugs Test kits, portable sniffers, Bullet-hole testing kits, and others. The Company currently sells its products to law enforcement organizations in the following countries Indonesia, Argentina, Poland, France, USA, Spain, India, the United Kingdom, Ghana, Nigeria, Australia, Russia, Israel, Canada, Germany, Italy, and Portugal. The Company also sells to retail markets in the United States, Italy, and South Africa.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Small Core
Total Number of Employees
25

Valuation

Metric
IDTA
Price/Earnings (Normalized)
21.35
Price/Book Value
1.74
Price/Sales
0.98
Price/Cash Flow
25.70
Price/Earnings
IDTA

Financial Strength

Metric
IDTA
Quick Ratio
2.74
Current Ratio
4.76
Interest Coverage
1.70
Quick Ratio
IDTA

Profitability

Metric
IDTA
Return on Assets (Normalized)
3.26%
Return on Equity (Normalized)
11.43%
Return on Invested Capital (Normalized)
5.49%
Return on Assets
IDTA
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
TMO
Thermo Fisher Scientific IncLrpyhcxpxrBkv$218.9 Bil
DHR
Danaher CorpXsjrzvlpZkkvt$184.3 Bil
IQV
IQVIA Holdings IncZrsbbsccQxwnjc$41.7 Bil
A
Agilent Technologies IncDwnfjbljnKqsg$40.9 Bil
IDXX
IDEXX Laboratories IncKcbvnwbxvQhspfn$40.0 Bil
MTD
Mettler-Toledo International IncYlcxffczgxXlcymn$26.8 Bil
ICLR
Icon PLCQlfjctsZhhjjw$26.1 Bil
WAT
Waters CorpPddfjdxfsXdrd$19.1 Bil
ILMN
Illumina IncPvzcdntDztqsgc$18.0 Bil
LH
Laboratory Corp of America HoldingsCnbzvhqfCktgbz$16.9 Bil

Sponsor Center